By contrast, the secretion of adiponectin, an adipokine with anti-inflammatory, anti-obesity, insulin sensitizing, and vasorelaxing, that is, metabotrophic activity (68, 69), is decreased in obesity and related vascular diseases (81–86). Here, ADIPOQ is linked to obesity disorder.